IRIS
LODI, Tiziana
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.056
EU - Europa 3.778
AS - Asia 2.192
SA - Sud America 117
AF - Africa 19
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 3
Totale 11.172
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.951
CN - Cina 1.272
IE - Irlanda 809
SG - Singapore 710
SE - Svezia 672
IT - Italia 649
FI - Finlandia 542
UA - Ucraina 478
DE - Germania 345
TR - Turchia 128
BR - Brasile 107
GB - Regno Unito 102
CA - Canada 98
FR - Francia 57
BE - Belgio 35
RU - Federazione Russa 19
NL - Olanda 17
ES - Italia 14
IN - India 13
BD - Bangladesh 11
CZ - Repubblica Ceca 9
CI - Costa d'Avorio 8
HK - Hong Kong 8
EU - Europa 7
JP - Giappone 7
ID - Indonesia 6
IR - Iran 6
VN - Vietnam 6
PH - Filippine 5
IQ - Iraq 4
MX - Messico 4
NO - Norvegia 4
RO - Romania 4
AR - Argentina 3
AT - Austria 3
AU - Australia 3
DK - Danimarca 3
EC - Ecuador 3
EG - Egitto 3
KR - Corea 3
MA - Marocco 3
RS - Serbia 3
AZ - Azerbaigian 2
CO - Colombia 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LT - Lituania 2
MK - Macedonia 2
NG - Nigeria 2
NP - Nepal 2
PL - Polonia 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
BA - Bosnia-Erzegovina 1
CL - Cile 1
DM - Dominica 1
DZ - Algeria 1
EE - Estonia 1
JM - Giamaica 1
LV - Lettonia 1
MC - Monaco 1
ME - Montenegro 1
PA - Panama 1
PK - Pakistan 1
PT - Portogallo 1
SN - Senegal 1
TH - Thailandia 1
UY - Uruguay 1
ZA - Sudafrica 1
Totale 11.172
Salva come PNG Salva come JPEG
Città #
Dublin 797
Chandler 791
Santa Clara 554
Jacksonville 537
Singapore 466
Ashburn 302
Ann Arbor 282
Dearborn 282
Beijing 257
Boardman 226
Nanjing 209
Parma 195
Princeton 155
San Mateo 132
Izmir 123
Wilmington 118
Shanghai 104
Toronto 83
Jinan 74
New York 71
Shenyang 70
Los Angeles 61
Nanchang 61
Hefei 55
Helsinki 55
Des Moines 54
Kunming 51
Woodbridge 50
Hebei 48
Brussels 33
Falls Church 30
Guangzhou 30
Jiaxing 30
Dosolo 26
Tianjin 25
Changsha 24
Seattle 23
Houston 20
Zhengzhou 19
Redmond 18
Bremen 16
Haikou 16
Padova 16
Council Bluffs 15
Fremont 14
Fuzhou 14
Hangzhou 14
Marseille 14
Bologna 13
Taizhou 13
Catania 12
Moscow 12
Modena 11
Norwalk 11
Phoenix 11
Redwood City 11
Lanzhou 10
Milan 10
Rockville 10
Auburn Hills 9
Dallas 9
London 9
Rome 9
Abidjan 8
Almería 8
Borås 8
São Paulo 8
Chongqing 7
Frankfurt am Main 7
Grafing 7
Gravina di Catania 7
Xian 7
Amsterdam 6
Belo Horizonte 6
Cordovado 6
Dong Ket 6
Jakarta 6
Messina 6
Ottawa 6
Pavia 6
Pune 6
Sorbolo 6
Taiyuan 6
Wenzhou 6
Wuhan 6
Davao City 5
Düsseldorf 5
Fairfield 5
Madrid 5
Nuremberg 5
Piacenza 5
Quzhou 5
Scafati 5
Ardea 4
Avola 4
Bodø 4
Brescia 4
Dronten 4
Falkenstein 4
Las Vegas 4
Totale 7.033
Salva come PNG Salva come JPEG
Nome #
Complete loss-of-function of the heart/muscle-specific adenine nucleotide translocator is associated with mitochondrial myopathy and cardiomyopathy 123
DNA polymerase [gamma] and disease: what we have learned from yeast 121
A yeast-based repurposing approach revealed modulation of dNTP pool as a therapeutic target to treat mitochondrial DNA depletion syndromes 121
Yeast, worm, patient’s fibroblasts and zebrafish as models for drug repositioning of molecules targeting POLG-related diseases 118
A chemical genomic approach to characterize the antiproliferative activity of metal based drugsdriven by phenotypic screening in yeast as a model organism 116
Genetic and chemical rescue of the Saccharomyces cerevisiae phenotype induced by mitochondrial DNA polymerase mutations associated with progressive externalophthalmoplegia in humans 110
Construction and validation of a yeast model system for studying in vivo the susceptibility to stavudine of DNA polymerase gamma allelic variants 108
Sabotage at the powerhouse? Unraveling the Molecular Target of 2-Isopropylbenzaldehyde Thiosemicarbazone, a Specific Inhibitor of Aflatoxin Biosynthesis and Sclerotia Development in Aspergillus flavus, Using Yeast as a Model System 108
Mechanistic insights on the mode of action of an antiproliferative thiosemicarbazone-nickel complex revealed by an integrated chemogenomic profiling study 107
COMPOUNDS FOR THE TREATMENT OF MITOCHONDRIAL DISEASES 105
A Klaac null mutant of Kluyveromyces lactis is complemented by a single copy of the Saccharomyces cerevisiae AAC1 gene 105
Drug repositioning as a therapeutic strategy for neurodegenerations associated with OPA1 mutations 105
Defective mitochondrial rRNA methyltransferase MRM2 causes MELAS-like clinical syndrome 104
Dominance of yeast aac2R96H and aac2R252G mutations, equivalent to pathological mutations in ant1, is due to gain of function 103
Biallelic Mutations of Methionyl-tRNA Synthetase Cause a Specific Type of Pulmonary Alveolar Proteinosis Prevalent on Réunion Island 103
IMP2, a nuclear gene controlling the mitochondrial dependence of galactose, maltose and raffinose utilization in Saccharomyces cerevisiae. 102
A chemical genomic approach to characterize the antiproliferative activity of metal-based drugs driven by phenotipic screening in yeast as a model organism 102
In vitro evaluation of the activity of thiosemicarbazone derivatives against mycotoxigenic fungi affecting cereals 101
Deciphering OPA1 mutations pathogenicity by combined analysis of human, mouse and yeast cell models 100
A single nucleotide polymorphism in the DNA polymerase gamma gene of Saccharomyces cerevisiae laboratory strains is responsible for increased mitochondrial DNA mutability 99
Behaviour of Saccharomyces cerevisiae wine strains during adaptation to unfavourable conditions of fermentation on synthetic medium: Cell lipid composition, membrane integrity, viability and fermentative activity 99
S. cerevisiae carrying a MGM1/OPA1 chimeric gene: a model for the study of dominant optic atrophy and for drug discovery 98
Screening of thiosemicarbazones as antimycotic drugs 97
Characterization of a promoter mutation in the CYP3 gene of S. cerevisiae which cancels regulation by Cyp1p (Hap1p) without affecting its binding site 96
Validation of a MGM1/OPA1 chimeric gene for functional analysis in yeast of mutations associated with dominant optic atrophy 96
Validation of a MGM1/OPA1 chimeric gene for functional analysis in yeast of mutations associated with dominant optic atrophy 96
COMPOUNDS FOR THE TREATMENT OF MITOCHONDRIAL DISEASES 95
Modification of nuclear gene expression by inhibition of mitochondrial translation during sporulation in MATa/Mata diploids of Saccharomyces cerevisiae. 93
Combined use of Saccharomyces cerevisiae, Caenorhabditis elegans and patient fibroblasts leads to the identification of Clofilium tosylate as a potential therapeutic chemical against POLG-related diseases 93
Secretion of human serum albumin from Kluyveromyces lactis over-expressing KlPDI1 and KlERO1 genes 92
Chiral Aminoacid Containing Acyclic Ligands. I. Syntheses and Conformations 91
Mutations in AAC2, equivalent to human adPEO-associated ANT1 mutations, lead to defective oxidative phosphorylation in Saccharomyces cerevisiae and affect mitochondrial DNA stability 90
Allelism of IMP1 and GAL2 genes of Saccharomyces cerevisiae 90
Construction and validation of a yeast model system for studying in vivo the susceptibility to stavudine of Polg allelic variants 89
Yeast as a model of mitochondrial dysfunctions: neurodegenerative diseases and cancer. 89
Polymorphisms in DNA polymerase γ affect the mtDNA stability and the NRTI-induced mitochondrial toxicity in Saccharomyces cerevisiae 89
The identification of beneficial molecules for mitochondrial diseases: Saccharomyces cerevisiae as powerful model 89
Amino and carboxy-terminal extensions of yeast mitochondrial DNA polymerase assemble both the polymerization and exonuclease active sites 89
Klaac null mutant in K. lactis is complemented by a single copy of S. cerevisiae “silent” gene AAC1 88
COMPOUNDS FOR THE TREATMENT OF MITOCHONDRIAL DISEASES 88
Mutations in AAC2, equivalent to human adPEO-associated ANT1 mutations, lead to defective oxidative phosphorylation in Saccharomyces cerevisiae and affect mitochondrial DNA stability 87
Catabolite repression by galactose in overexpressed GAL4 strains of Saccharomyces cerevisiae 86
Structural modification of cuminaldehyde thiosemicarbazone increases inhibition specificity toward aflatoxin biosynthesis and sclerotia development in Aspergillus flavus 86
Cloning and characterization of the lactate-specific inducible gene KlCYB2, encoding the cytochrome b2 of Kluyveromyces lactis 85
Overexpression of DNA Polymerase Zeta Reduces the Mitochondrial Mutability Caused by Pathological Mutations in DNA Polymerase Gamma in Yeast 85
The Power of Yeast in Modelling Human Nuclear Mutations Associated with Mitochondrial Diseases 85
A mitochondrial role in pseudohyphal constitutive mutants obtained from a natural Saccharomyces cerevisiae strain 84
“Espressione e secrezione di una Major Urinary Protein di topo nel lievito metilotrofo Pichia pastoris” 84
“Expression and structural characterization of a recombinant mouse major urinary protein” 83
Construction of a yeast model system for studying in vivo susceptibility to stavudine of Polg allelic variants 82
A yeast-based screening unravels potential therapeutic molecules for mitochondrial diseases associated with dominant ant1 mutations 82
Carbon catabolite repression in Kluyveromyces lactis: isolation and characterization of the KlDLD gene encoding the mitochondrial enzyme D-lactate ferricytochrome c oxidoreductase. 80
LYS2 gene and its mutation in Kluyveromyces lactis 79
“Expression of a lipocalin in Pichia pastoris: secretion, purification and binding activity of a recombinant Major Urinary Protein” 79
Yeast expression of mammalian Onzin and fungal FCR1 suggests ancestral functions of PLAC8 proteins in mitochondrial metabolism and DNA repair 79
Saccharomyces cerevisiae as a system to discover beneficial molecules for mitochondrial diseases 78
Efficient clofilium tosylate-mediated rescue of POLG-related disease phenotypes in zebrafish 78
Elementi regolativi implicati nel processo di repressione /derepressione da glucosio in Kluyveromyces lactis: differenze rispetto a Saccharomyces cerevisiae 77
Construction and characterization of centromeric, episomal and GFP-containing vectors for Saccharomyces cerevisiae prototrophic strains 77
Saccharomyces cerevisiae, a model system to study the effect of mtDNA polymerase mutations associated with PEO in humans. 77
Investigation of mupirocin susceptibility in bifidobacteria: physiological and genetic insights. 77
Modeling of pathogenic variants of mitochondrial DNA polymerase: insight into the replication defects and implication for human disease 77
A yeast-based repurposing approach for the treatment of mitochondrial DNA depletion syndromes led to the identification of molecules able to modulate the dNTP pool 77
Effetti fenotipici e funzionali di mutazioni del gene ANT1 responsabili della patologia umana adPEO nel lievito Saccharomyces cerevisiae 76
The mitochondrial disulfide relay system protein GFER is mutated in autosomal-recessive myopathy with cataract and combined respiratory-chain deficiency. 76
Construction and validation of a yeast model system for studying in vivo the susceptibility to nucleoside analogues of DNA polymerase gamma allelic variants. 76
Expression of a lipocalin in Pichia pastoris: secretion, purification and binding activity of a recombinant Major Urinary Protein 75
Carboxylic acids permeases in yeast: two genes in Kluyveromyces lactis.” 75
Regolazione del gene JEN1, codificante la lattato permeasi, nel lievito Saccharomyces cerevisiae 74
L'aumento del dosaggio del gene ero1 favorisce la secrezione di proteine ricombinanti in Kluyveromyces lactis 74
Klaac null mutant in K.lactis is complemented by a single copy of S.cerevisiae gene AAC1 73
Comparative Functional Genomics of glucose repression in laboratory and wine yeasts 73
Overexpression of DNA polymerase zeta reduces the mitochondrial mutability caused by pathological mutations in DNA polymerase gamma in yeast. 73
MIG1-dependent and MIG1-independent regulation of GAL gene expression in Saccharomyces cerevisiae: role of IMP2p 72
Antimycin- and hydroxamate-insensitive respiration in yeast 72
Overexpression of DNA polymerase zeta and Rev1 reduces the mitochondrial mutability caused by pathological mutations in DNA polymerase gamma in yeast. 72
“MAJOR URINARY PROTEINS: STUDIES ON THE BINDING OF FLUORESCENT MOLECULES AND ITS 13C AND 15N ENRICHED EXPRESSION IN PICHIA PASTORIS” 71
A variable neurodegenerative phenotype with polymerase gamma mutation 71
Lipid Metabolism Related To Stuck Fermentation In Saccharomyces cerevisiae Wine Strains 70
Rescue by Pol zeta overexpression of mitochondrial DNA instability due to mutations in Pol gamma in S. cerevisiae 70
Predicting the contribution of novel POLG mutations to human disease through analysis in yeast model 70
Klaac null mutant in Kluyveromycs lactis is complemented by a single copy of Saccharomyces cerevisiae gene AAC1 70
Mitmed: a multicenter consortium for the identification and characterization of nuclear genes responsisble for human mitochondrial disorders 70
DEFECTIVE MITOCHONDRIAL rRNA METHYLTRANSFERASE (MRM2) CAUSES A MELAS-LIKE SYNDROME 69
Yeast as a model for drug discovery: Identification of a molecule acting as potential therapeutics for POLG-related diseases 69
Influence of leucine metabolism on Saccharomyces cerevisiae dimorphism 68
Characterization of KlGUT2, a gene of the glycerol-3-phosphate shuttle, in Kluyveromyces lactis 68
Identificazione dei bersagli della proteina Imp2p in Saccharomyces cerevisiae 67
Yeast as a model for drug discovery: identification of a molecule acting as potential therapeutics for POLG-related diseases 67
Galactose transport in Kluyveromyces lactis: major role of the glucose permease Hgt1 66
Galactose transport in Kluyveromyces lactis: a genomic approach 66
Mutations in AAC2, equivalent to human adPEO-associated ANT1 mutations, lead to defective oxidative phosphorylation in Saccharomyces cerevisiae and affect mitochondrial DNA stability 65
“La proteina feromonale Major Urinary Protein: struttura della proteina ricombinante ed indagini molecolari sull’organo sensoriale del sistema olfattivo feromonale” 65
Co-ordinated regulation of lactate metabolism genes in yeast: role of lactate permease gene JEN1 65
Defective mitochondrial rRNA methyltransferase MRM2 causes MELAS-like clinical syndrome 65
Il lievito come modello per lo studio di patologie mitocondriali umane 64
FOG1 and FOG2 genes, required for the transcriptional activation of glucose-repressible genes of Kluyveromyces lactis are homologous to GAL83 and SNF1 of Saccharomyces cerevisiae 64
Studio del sistema ADP/ATP carrier in Kluyveromyces lactis: effetti fenotipici della distruzione del gene KlAAC e della introduzione del gene ScAAC1 nel mutante derivato. 64
Yeast as a model for drug repositioning: analysis of molecules acting as potential therapeutics for POLG-related diseases 64
Il metabolismo lipidico di ceppi vinari di Saccharomyces cerevisiae e gli arresti di fermentazione 64
Totale 8.445
Salva come PNG Salva come JPEG
Categoria #
all - tutte 41.639
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.639
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020574 0 0 0 0 0 0 0 0 239 170 44 121
2020/20211.141 22 119 111 26 154 40 138 45 229 41 172 44
2021/2022787 22 16 15 36 25 24 103 120 34 67 50 275
2022/20232.873 312 276 217 220 232 329 28 193 934 18 87 27
2023/20241.028 54 86 33 30 89 241 85 112 15 88 80 115
2024/20251.818 36 176 191 224 385 505 103 132 66 0 0 0
Totale 11.404